Table 5.

Mean values (± SE) of the anthropometric features (i.e., weight, height, and body mass index) and cardiocirculatory markers (i.e., systolic pressure, diastolic pressure, pulse pressure, mean arterial pressure, and heart frequency) as well as the results of their statistical comparisons (T-test on log-10 transformed data; p < 0.05 corrected) in the groups of noADMCI-noEEA (N = 19) and noADMCI-EEA (N = 13) patients.

	noADMCI-noEEA	noADMCI-EEA	T-test
Anthropometric markers, blood pressure and pulse in noADMCI-noEEA and noADMCI-EEA
Weight (kg)	72 ± 4 (N = 19)	71 ± 4 (N = 12)	p = 0.4
Height (cm)	163 ± 3 (N = 19)	157 ± 2 (N = 12)	p = 0.03
Body mass index (BMI)	26.9 ± 0.9 (N = 19)	29.1 ± 1.8 (N = 12)	p = 0.1
Systolic pressure (mmHg)	122± 8 (N = 18)	135 ± 4 (N = 11)	p = 0.2
Diastolic pressure (mmHg)	73 ± 3 (N = 18)	76 ± 4 (N = 11)	p = 0.3
Pulse pressure (mmHg)	55 ± 4 (N = 18)	59 ± 5 (N = 11)	p = 0.2
Mean arterial pressure (MAP, mmHg)	92 ± 3 (N = 18)	95 ± 3 (N = 11)	p = 0.2
Heart frequency/min	67 ± 3 (N = 18)	66 ± 3 (N = 11)	p = 0.4

The table also reports the number of participants for which the values of those markers were available.

noADMCI-noEEA, patients with mild cognitive impairment not due to Alzheimer's disease and without epileptiform EEG activity; noADMCI-EEA, patients with mild cognitive impairment not due to Alzheimer's disease and epileptiform EEG activity. A marginal difference was observed between the two noADMCI groups when a marginal threshold of p < 0.05 uncorrected was used. Namely the height was higher in the noADMCI-no EEA than the noADMCI-EEA group.